Russia completes clinical trials of second potential COVID-19 vaccine
The institute completed early-stage human trials, known as Phase II, earlier this month.
September 30, 2020 / 02:15 PM IST
Russia has completed clinical trials of a second potential vaccine against COVID-19, developed by Siberia's Vector Institute, the RIA news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Wednesday.
Follow our LIVE blog for the latest updates of the novel coronavirus pandemic
The institute completed early-stage human trials, known as Phase II, earlier this month.Follow our full coverage of the coronavirus pandemic here.